PTPI
Petros Pharmaceuticals, Inc.Company Information
- Company Name
- Petros Pharmaceuticals, Inc.
- CIK
- CIK0001815903
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- PTPI: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PTPI
SEC filing data through
Insider Sentiment
- Last purchase
- 2021-12-22
- Last sale
- —
- Shares purchased (TTM)
- 2,307,580
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2025-06-30
- Institutional shares owned
- 200
- Shares outstanding
- 25,922,503
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 100.00%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series Convertible Preferred Stock | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 6 | - | ||||||
| Series B Convertible Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Temporary Equity Value Excluding Additional Paid In Capital | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Authorized | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Issued | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Outstanding | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Liquidation Preference | - | - | - | - | - | - | - | 1 | 5 | 6 | 11 | 15 | ||||||
Assets Current | ||||||||||||||||||
| Assets Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | 5 | 6 | - | - | - | - | - | ||||||
| Inventory Net | - | - | - | - | - | - | 1 | 1 | 1 | 2 | 2 | 3 | ||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 4 | 5 | 6 | 7 | 9 | 2 | 4 | 7 | 11 | 13 | 18 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 1 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | 0 | 2 | 2 | 2 | 2 | 3 | ||||||
| Assets Current | 4 | 4 | 5 | 6 | 7 | 14 | 7 | 11 | 14 | 18 | 20 | 24 | ||||||
| Advances On Inventory Purchases | - | - | - | - | - | - | 2 | 2 | 1 | 1 | 1 | - | ||||||
| Disposal Group Including Discontinued Operation Assets Noncurrent | - | - | - | - | - | 3 | 3 | - | - | - | - | - | ||||||
| Assets | 4 | 4 | 5 | 6 | 7 | 18 | 11 | 21 | 25 | 30 | 34 | 39 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Inventory Noncurrent | - | - | - | - | - | - | - | 3 | 3 | 4 | 4 | 4 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | 3 | 7 | 8 | 8 | 9 | 10 | ||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 7 | 7 | 6 | 5 | 4 | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Payable Preferred Stock Redeemed | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 | 1 | 2 | 1 | ||||||
| Warrants And Rights Outstanding | - | 0 | 0 | 0 | 0 | 8 | - | - | - | - | - | - | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | - | - | - | - | - | 16 | 15 | - | - | - | - | - | ||||||
| Notes Payable Current | - | - | - | - | - | - | 7 | 2 | 2 | 2 | 1 | 1 | ||||||
| Liabilities Current | 3 | 3 | 2 | 3 | 3 | 27 | 18 | 13 | 10 | 11 | 11 | 8 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | 5 | 6 | 6 | 7 | 7 | ||||||
| Liabilities Of Disposal Group Including Discontinued Operation Noncurrent | - | - | - | - | - | 0 | 0 | - | - | - | - | - | ||||||
| Liabilities | 3 | 3 | 2 | 3 | 3 | 27 | 18 | 18 | 16 | 20 | 21 | 32 | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | - | 0 | 1 | 1 | 0 | 0 | ||||||
| Other Liabilities Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Derivative Liabilities | - | - | - | - | - | - | 0 | - | 0 | 2 | 4 | 7 | ||||||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | - | - | - | - | - | - | - | - | - | - | - | 10 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 114 | 114 | 114 | 114 | 114 | 106 | 106 | 107 | 110 | 111 | 111 | 106 | ||||||
| Other Liabilities Noncurrent | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -113 | -112 | -111 | -111 | -110 | -115 | -113 | -104 | -102 | -101 | -99 | -99 | ||||||
| Stockholders Equity | 1 | 2 | 3 | 3 | 4 | -10 | -7 | 3 | 8 | 10 | 12 | 7 | ||||||
| Liabilities And Stockholders Equity | 4 | 4 | 5 | 6 | 7 | 18 | 11 | 21 | 25 | 30 | 34 | 39 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | ||||||
| Common Stock Shares Issued | 42 | 42 | 42 | 42 | 42 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 42 | 42 | 42 | 42 | 42 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPetros Pharmaceuticals, Inc. (PTPI) — SEC Financial Statements & Analysis
Petros Pharmaceuticals, Inc. (PTPI) is a pharmaceutical preparations company, incorporated in DE. Petros Pharmaceuticals, Inc. trades on OTC as: PTPI. Petros Pharmaceuticals, Inc. (PTPI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Petros Pharmaceuticals, Inc. carries a market cap of $236.96K, a P/E ratio of -0.07x, a P/B ratio of 0.34x, a P/S ratio of 3.53x, an enterprise value of $-3.25M, and an EV/EBITDA multiple of 0.96x. On profitability, it posts a gross margin of 164.54%, an operating margin of -692.62%, a net margin of -731.79%, a Return on Equity (ROE) of -124.40%, a Return on Assets (ROA) of -58.52%, and a Return on Invested Capital (ROIC) of -405.22%. Per share, it reports EPS of $-0.07, diluted EPS of $-0.07, free cash flow per share of $-0.08, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -48.76% year-over-year, and EPS growth of -71.97% year-over-year. On the balance sheet, it maintains a current ratio of 1.25x, a quick ratio of 1.23x, working capital of $700.89K, a debt-to-equity ratio of 4.06x, a debt ratio of 0.8, an interest coverage ratio of -17.66x, free cash flow of $-3.72M (TTM), and net debt of $-3.49M. Figures sourced from SEC EDGAR.
- Market Cap
- $236.96K
- P/E TTM
- -0.07x
- EPS TTM
- $-0.07
- P/B TTM
- 0.34x
- ROE TTM
- -124.40%
- ROA TTM
- -58.52%
- Debt To Equity
- 4.06x
- Free Cash Flow TTM
- $-3.72M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Petros Pharmaceuticals, Inc. in?
Petros Pharmaceuticals, Inc. (PTPI) operates in the Pharmaceutical Preparations industry.
What exchange does PTPI trade on?
Petros Pharmaceuticals, Inc. (PTPI) trades on the OTC.
Where is Petros Pharmaceuticals, Inc. incorporated?
Petros Pharmaceuticals, Inc. is incorporated in DE.
When was Petros Pharmaceuticals, Inc. (PTPI)'s most recent SEC filing?
Petros Pharmaceuticals, Inc. (PTPI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is PTPI's market cap?
Petros Pharmaceuticals, Inc. (PTPI) has a market capitalization of $236.96K as of 2026-06-30.
What is PTPI's EPS (earnings per share)?
Petros Pharmaceuticals, Inc. (PTPI)'s trailing twelve month EPS is $-0.07 as of 2026-06-30.
What is PTPI's ROE (return on equity)?
Petros Pharmaceuticals, Inc. (PTPI)'s trailing twelve month Return on Equity (ROE) is -124.40% as of 2026-06-30.
What is PTPI's ROA (return on assets)?
Petros Pharmaceuticals, Inc. (PTPI)'s trailing twelve month Return on Assets (ROA) is -58.52% as of 2026-06-30.
What is PTPI's ROIC (return on invested capital)?
Petros Pharmaceuticals, Inc. (PTPI)'s trailing twelve month Return on Invested Capital (ROIC) is -405.22% as of 2024-09-30.
What is PTPI's EV/EBITDA?
Petros Pharmaceuticals, Inc. (PTPI)'s trailing twelve month EV/EBITDA is 0.96x as of 2026-06-30.